[244 Pages Report] The global demand for corneal ulcer treatment market is expected to experience a significant growth of 5.7% CAGR from 2022 to 2029, with an estimated market value of around US$ 867.3 Mn as of 2022. As per Future Market Insights’ projections, Antibiotics hold a substantial share of around 76.4% in 2021 within the global market.
Market Outlook:
Data Points
Market Insights
Market Value 2021
US$ 817.9 million
Market Value 2022
US$ 867.3 million
Market Value 2029
US$ 1.27 billion
CAGR 2022-2029
5.7%
Market Share of Top 5 Countries
72%
Corneal ulcer treatment market holds nearly 2.7% market share in the overall Ophthalmology therapeutics market valued at around 30 Bn in 2021.
A corneal ulcer is an open sore on the cornea. Cornea covers iris and pupil of the eye. It is also known as keratitis. If it is left untreated, corneal ulcers can hamper vision causing permanent scarring. Normal treatments for this condition involve surgical treatment in which the damaged cornea is replaced by a healthy donor cornea. After infection subsides, ulcer is further treated with additional medication.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
5.72%
H1, 2022 Projected
5.72%
H1, 2022 Outlook
5.72%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 13 ↓
FMI provides a comparative study of the global corneal ulcer treatment market's growth rates and development prospects. Product adoption of contact lens, as well as the impact of macro and industrial factors, have an impact on the market.
Due to advancements in medical administration and microsurgical techniques, the frequency of corneal perforations has reduced in recent decades, resulting in improved outlook for corneal ulcers and a diminution in complications associated with the condition, and is a key impeding factor in this sector.
According to FMI, the corneal ulcer treatment market will drop by 13 basis point share (BPS) in H1-2022 (O) as compared to H1-2021. Furthermore, on comparing H1-2022 projected and H1-2022 outlook period, the declining growth rate is expected by nearly 10 BPS for this market.
One of the main reasons for the deterioration in BPS is corneal scarring, vascularization, or perforation, glaucoma, uneven astigmatism, cataracts, endophthalmitis, and vision loss, which are all complications of untreated or improperly treated corneal ulcers.
The surgical management of corneal ulcerations and perforations, can conversely provide a lucrative growth impact on the corneal ulcer treatment market.
Sales Analysis Of Corneal Ulcer Treatment Market From 2014 To 2021 Vs Market Outlook For 2022 To 2029
Global corneal ulcer treatment sales were valued at around US$ 817.9 Mn at the end of 2021. The development of innovative medical treatments has witnessed a high boost over the past few years. In comparison to the traditional methods for ulcer treatment, researchers are adding value to this domain by creating various cost-effective treatment options.
The corneal ulcer treatment displays a substantial number of benefits to the patients which include enhanced diagnostics capabilities, minor incisions during surgery, greater precision, lower risks of infections, better patient outcomes with a reduced time for healing, and longer lifespan.
Currently many such novel treatments are undergoing clinical trials. Most of the current treatment methods include drug related therapies, scientists also are working in order to develop new drugs to treat corneal ulcer.
The current corneal ulcer treatment market includes different drug types such as antibiotics, antifungals, antivirals and many more. By drug type, antibiotics was the dominant market segment in global market in 2021 which contributed 76.4% of the revenue share due to its effective action against disease causing pathogens.
The applications for improvement of corneal ulcer treatment are set to rise in number with increase in awareness of treatment methods, proper usage of contact lenses in order to improve the health of people with and expedite healing process. The global corneal ulcer treatment market is expected to be valued at US$ at 1.27Bn by the end of 2029 and is projected to register a CAGR of 5.7% in the forecast period.
What Are The Key Opportunities For Corneal Ulcer Treatment Manufacturers?
Manufacturers in the global corneal ulcer treatment are primarily focussing on enhancing their regional product offering because they want to cater a larger patient audience. Medical researchers are constantly developing new and innovative strategies to tune treatments for corneal ulcer treatment.
Various novel treatment options are for bacterial keratitis, fungal keratitis is undergoing clinical trials. Increasing the number of R&D activities for developing new drugs for treatment is one of the important factors which is expected to grow in market in the forecasted years.
Awareness of proper usage of contact lenses is also an important factor because it is closely linked to corneal ulcer. Especially in countries like India, where majority of our population is into agricultural activities are likely to be prone to corneal ulcers. These following opportunities could fuel the demand for manufacturers to expand their units and increase the production of the treatment options in order to serve the growing patient audience.
Find your sweet spots for generating winning opportunities in this market.
What Are The Factors Restraining Demand For Corneal Ulcer Treatment?
Antibiotics are primarily used to treat bacterial keratitis. With excessive use of antibiotics comes the alarming concern of antibiotic resistance. When many antibiotics are consumed to treat keratitis, micro-organisms can become resistant to that particular medication and in turn the infection will not be treated adequately. Hence there is a dire need of addressing this problem.
Various modern therapy options for corneal ulcer treatment are costly and are have limited availability. By hindering product acceptance, this prevents potential patient care as well as income generation. Natamycin, for example, is the primary anti-fungal medication for treating fungal keratitis, but it is quite expensive and in limited supply in developing countries. These factors could indeed hamper the growth of corneal ulcer treatment market in long term if not addressed.
Country-Wise Insights
What Makes the U.S. the Largest Market for Corneal Ulcer Treatment?
The U.S. dominates the North American region with a total market share of over 87.3% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of this market is driven by the high number of people using contact lenses. Additionally, the growth in the country is also associated with increase in epidemiological data and rise in awareness about various treatment options.
Why is U.K. Considered a Lucrative Market for Corneal Ulcer Treatment in Europe?
U.K. is set to exhibit a CAGR of over 5.7% in the European corneal ulcer treatment market during the forecast period. U.K. is at the topmost leading position when it comes to R&D in Europe. Main driver for this market is that U.K. has sophisticated infrastructure and cutting edge technology which will help expedite the treatment development options for corneal ulcer.
What Makes China an Emerging Market for Corneal Ulcer Treatment?
China is projected to increase at a CAGR rate of 7% during the forecast period. The growth of the corneal ulcer treatment market in the country is attributed to the rising wave of innovation therapy strategies in the region of East Asia, with China as the prime contributor in the development industry for drugs to treat various infections as well as highest consumers of contact lens usage in eastern Asia.
What makes India a lucrative market for Corneal Ulcer Treatment?
India is set to witness an increase in CAGR of 6.7% during the forecast years. India has a higher incidence rate of corneal ulcer as compared to other south Asian countries hence this makes India a lucrative region for the local players to collaborate with giant players in the market and increase the manufacturing of various treatment options and enhancing their product portfolio.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-Wise Insights
Which Corneal ulcer treatment Drug class is driving the market growth?
Drug class of antibiotics contributes about 76.4% of market share in 2021 and is expected to have a CAGR of 5.8% in the forecast period. The growth is associated with the ability of antibiotics to be fast acting, their low cost and their efficiency to act on a broad spectrum of bacteria especially its efficacy in treatment of corneal ulcer treatment compared to other drug classes.
Which Distribution channel Benefits the most by Employment of Corneal Ulcer Treatment?
Hospital pharmacies benefit the most in this segment with market share of more than 36% share in revenue and is expected to grow with a CAGR of 5.4% in the forecast period. They are the main components because the drugs used in treatment are easily available, they will have better access to medical records of patients and there will be increased interaction with health care professionals and treatment facilities.
Which indication category is in the lead of driving the market growth?
Bacterial keratitis is in the lead as it is caused by normal opportunistic flora like Pseudomonas and Staphylococcus which can cause increase infection rate due to prolonged use of contact lenses, weak immune system. It has a valuation of U.S. $ 409.8Mn in 2021 and is expected to increase with a CAGR of 5.8% in the forecast period.
Bacterial infections are the most likely cause of corneal ulcers and generalised drug therapy is available which is suitable for all. For example, USA has an incidence of 11 per 100,000 persons for microbial keratitis.
Which category by Form is mostly benefitting to increase market growth for corneal ulcer treatment?
Tablets are a major driving component for increasing market growth and is expected to show a CAGR of 3.5% in the forecast years. Tablets are easy to administer, they have longer shelf life, they can accommodate a higher dose of active ingredient and they usually have a fast release mechanism.
What is the Impact of COVID-19 on the corneal ulcer treatment Industry?
The COVID-19 pandemic originally had a restrictive impact on growth of corneal ulcer treatment market. This impact was registered principally due to the guidelines published by different regulatory bodies, advising that patients getting treatment for non-urgent medical issues are at a greater risk of spread of COVID-19 infections.
The rise in the prevalence of infectious diseases, chronic diseases and the increasing disease burden over the globe due to the COVID-19 pandemic led to advancements in current treatment options as well as novel innovative therapy formation.
Competitive Landscape
Leading corneal ulcer treatment manufacturers are focusing on geographical expansion to gain high revenue & expand their sales footprint in emerging countries by acquisition of local market players.
Strategic collaborations, acquisitions, expansion, product launches, agreements and research sponsorship are the key strategies adopted by manufacturers to increase the product sales in different geographies.
In December, 2019 Mallinckrodt plc enrolled its first in company’s Phase 4 multi centre, multiple- dose, open-label study to assess the effects of Achtar Gel as a therapy for patients with severe keratitis.
In 2019, Dr Reddy’s Laboratory had filed 20 new Abbreviated New Drug Applications with USFDA.
Similarly, recent developments related to companies manufacturing corneal ulcer treatment products have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope
Attribute
Details
Forecast Period
2022-2029
Historical Data Available for
2014-2021
Market Analysis
US$ million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Turkey and South Africa
Key Market Segments Covered
Drug class, Form, Indication, Route of administration, Distribution channel and Region
Key Companies Profiled
Pfizer Inc.
Allergen plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Mallinckrodt Pharmaceuticals
Dr Reddy’s Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Baxter International Inc.
Fresenius Kabi
Pricing
Available upon Request
Key Market Segments Covered In Corneal Ulcer Treatment Industry Research
By Drug class:
Antibiotics
Antifungals
Antivirals
Corticosteroids
NSAID’s
By Form:
Tablet
Eye Drops/ Ointments
Vials
By Route of Administration:
Oral
Topical
Injectables
By Indication:
Bacterial Keratitis
Fungal Keratitis
Viral Keratitis
Acanthamoeba Keratitis:
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
By Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
The global corneal ulcer treatment market is worth US$ 817.94 Mn at present and is set to expand 1.5X times over the next seven years.
The corneal ulcer treatment market is expected to reach US$ 1.27 Bn by end of 2029 at a CAGR of 5.7%
The key trends for growth of corneal ulcer treatment include excessive usage of contact lens improving awareness about potential risk factors that cause corneal cancer, increasing investments in R&D and development of novel treatment therapies.
The key restraints affecting growth of corneal ulcer treatment include increase in prevalence of antibiotic resistance and the higher cost of drugs which are used in novel treatment of corneal ulcer.
The North American region has the highest market share of 26% by value in the global corneal ulcer treatment market.
Better corneal ulcer diagnosis, aided by unambiguous signs and symptoms, and, more crucially, established criteria, can result in huge revenue creation prospects. This opportunity will be most beneficial for growth in this market.
The U.S., China, Germany, Japan, and India are the top five countries which are expected to drive demand in corneal ulcer treatment market.
Pfizer Inc, Bayer AG, Allergen plc, Novartis AG,Teva Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals. Dr Reddy’s Pharmaceuticals. Sun Pharmaceutical Industries Ltd. Baxter International Inc., Fresenius Kabi are the key manufacturers in this market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting The Market
3.2. Corneal Ulcer Treatment Therapy Adoption, By Region
4. Market Context
4.1. Disease Epidemiology
5. Global Corneal Ulcer Treatment Market Demand (Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029 in Value or
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors - Relevance & Impact
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Drug Class
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022-2029
7.3.1. Antibiotics
7.3.2. Antifungals
7.3.3. Antivirals
7.3.4. Anti-amoebic Drugs
7.3.5. Corticosteroids
7.3.6. NSAID
7.4. Market Attractiveness Analysis By Drug Class
8. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Form
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Form, 2014-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2022-2029
8.3.1. Tablets
8.3.2. Eye Drops / Ointments
8.3.3. Vials
8.4. Market Attractiveness Analysis By Form
9. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2029
9.3.1. Oral
9.3.2. Topical
9.3.3. Injectable
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022 - 2029
10.3.1. Bacterial Keratitis
10.3.2. Fungal Keratitis
10.3.3. Viral Keratitis
10.3.4. Acanthamoeba Keratitis
10.4. Market Attractiveness Analysis By Indication
11. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2029
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. Online Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Drug Class
13.3.3. By Form
13.3.4. By Route of Administration
13.3.5. By Indication
13.3.6. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Latin America Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Drug Class
14.3.3. By Form
14.3.4. By Route of Administration
14.3.5. By Indication
14.3.6. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. Europe Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Drug Class
15.3.3. By Form
15.3.4. By Route of Administration
15.3.5. By Indication
15.3.6. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. South Asia Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Drug Class
16.3.3. By Form
16.3.4. By Route of Administration
16.3.5. By Indication
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. East Asia Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Drug Class
17.3.3. By Route of Administration
17.3.4. By Indication
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Oceania Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Drug Class
18.3.3. By Form
18.3.4. By Route of Administration
18.3.5. By Indication
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Rest of Middle East and Africa
19.3.2. By Drug Class
19.3.3. By Form
19.3.4. By Route of Administration
19.3.5. By Indication
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints - Impact Analysis
20. Emerging Countries Corneal Ulcer Treatment Market Analysis 2014-2021 and Forecast 2022-2029
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Corneal Ulcer Treatment Market Analysis
20.2.1. Introduction
20.2.2. Market Value Proportion Analysis by Market Taxonomy
20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.3.1. By Drug Class
20.2.3.2. By Form
20.2.3.3. By Route of Administration
20.2.3.4. By Indication
20.2.3.5. By Distribution Channel
20.2.4. China Corneal Ulcer Treatment Market - Competition Landscape
20.3. India Corneal Ulcer Treatment Market Analysis
20.3.1. Introduction
20.3.2. Market Value Proportion Analysis by Market Taxonomy
20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.3.1. By Drug Class
20.3.3.2. By Form
20.3.3.3. By Route of Administration
20.3.3.4. By Indication
20.3.3.5. By Distribution Channel
20.3.4. India Corneal Ulcer Treatment Market - Competition Landscape
20.4. Brazil Corneal Ulcer Treatment Market Analysis
20.4.1. Introduction
20.4.2. Market Value Proportion Analysis by Market Taxonomy
20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.3.1. By Drug Class
20.4.3.2. By Form
20.4.3.3. By Route of Administration
20.4.3.4. By Indication
20.4.3.5. By Distribution Channel
20.4.4. Brazil Corneal Ulcer Treatment Market - Competition Landscape
21. Market Structure Analysis
21.1. Market Concentration
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional Footprint of Players
21.3.2. Product Footprint by Players
21.3.3. Channel Footprint by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive (Tentative List)
22.3.1. Pfizer Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Analyst commentary
22.3.2. Allergan plc
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Analyst commentary
22.3.3. Novartis AG
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Analyst commentary
22.3.4. Bayer AG
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Analyst commentary
22.3.5. Teva Pharmaceutical Industries Ltd.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Analyst commentary
22.3.6. Mallinckrodt Pharmaceuticals
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Analyst commentary
22.3.7. Dr. Reddy’s Laboratories Ltd.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Analyst commentary
22.3.8. Sun Pharmaceutical Industries Ltd.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Analyst commentary
22.3.9. Baxter International Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Analyst commentary
22.3.10. Fresenius Kabi
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Analyst commentary
23. Assumptions and Acronyms Used24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 02: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 03: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 04: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 05: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 06: Global Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region
Table 07: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 08: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 09: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 10: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 11: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 12: North America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 13: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 14: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 15: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 16: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 17: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 18: Latin America Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 19: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 20: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 21: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 22: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 23: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 24: Europe Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 25: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 26: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 27: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 28: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 29: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 30: South Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 31: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 32: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 33: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 34: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 35: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 36: East Asia Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 37: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 38: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 39: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 40: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 41: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 42: Oceania Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 43: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 44: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 45: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 46: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 47: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 48: MEA Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 49: China Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 50: China Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 51: China Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 52: China Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 53: China Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 54: India Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 55: India Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 56: India Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 57: India Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 58: India Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 59: Brazil Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class
Table 60: Brazil Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Indication
Table 61: Brazil Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Form
Table 62: Brazil Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration
Table 63: Brazil Corneal Ulcer Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
